Anaeropharma Science

OverviewSuggest Edit

Anaeropharma Science is a biopharmaceutical company, established to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, i-DPS (in situ Delivery and Production System) utilizing recombinant bifidobacterium. The company aims to leverage the recombinant bifidobacterium technology to create a new class of anti-cancer drugs.

TypePrivate
Founded2004
HQChiyoda City, JP
Websiteanaeropharma.co.jp

Latest Updates

Employees (est.) (Oct 2020)5(-16%)
Cybersecurity ratingAMore

Key People/Management at Anaeropharma Science

Tetsuya Mishima

Tetsuya Mishima

President and CEO
Yuji Yamada

Yuji Yamada

Director
Nobutake Morii

Nobutake Morii

Director
Takehiko Sawabe

Takehiko Sawabe

Director
Kentaro Yoshimatsu

Kentaro Yoshimatsu

Director
Show more

Anaeropharma Science Office Locations

Anaeropharma Science has offices in Chiyoda City and Matsumoto
Chiyoda City, JP (HQ)
Tower 201, 1-chōme-103 Kanda Jinbōchō
Matsumoto, JP
3-chōme-1-1 Asahi
Show all (2)

Anaeropharma Science Financials and Metrics

Summary Metrics

Founding Date

2004

Anaeropharma Science total Funding

$13.2 m

Anaeropharma Science latest funding size

$13.20 m

Time since last funding

3 years ago

Anaeropharma Science investors

Anaeropharma Science's latest funding round in July 2017 was reported to be $13.2 m. In total, Anaeropharma Science has raised $13.2 m
Show all financial metrics

Anaeropharma Science Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Anaeropharma Science Online and Social Media Presence

Embed Graph

Anaeropharma Science News and Updates

Anaeropharma Science unterzeichnet gemeinsame Forschungsvereinbarung mit Astellas zur Entwicklung neuartiger Anti-Tumor-Medikamente auf Grundlage von Bifidobacterium

TOKIO, 25. September 2018 /PRNewswire/ -- Wie Anaeropharma Science Inc. mit Sitz in Tokio (nachfolgend „Anaeropharma") am 25. September bekanntgab, haben Anaeropharma und Astellas Pharma Inc. mit Sitz in Tokio (nachfolgend „Astellas") eine gemeinsame Forschungsvereinbarung unterzeichnet....

Anaeropharma Science Blogs

Anaeropharma Science Frequently Asked Questions

  • When was Anaeropharma Science founded?

    Anaeropharma Science was founded in 2004.

  • Who are Anaeropharma Science key executives?

    Anaeropharma Science's key executives are Tetsuya Mishima, Yuji Yamada and Nobutake Morii.

  • How many employees does Anaeropharma Science have?

    Anaeropharma Science has 5 employees.

  • Who are Anaeropharma Science competitors?

    Competitors of Anaeropharma Science include Univercells, Ginkgo Bioworks and Ra Pharmaceuticals.

  • Where is Anaeropharma Science headquarters?

    Anaeropharma Science headquarters is located at Tower 201, 1-chōme-103 Kanda Jinbōchō, Chiyoda City.

  • Where are Anaeropharma Science offices?

    Anaeropharma Science has offices in Chiyoda City and Matsumoto.

  • How many offices does Anaeropharma Science have?

    Anaeropharma Science has 2 offices.